Study S000795

Treatment of Bile Acid Malabsorption With Liraglutide

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03955575
Acronym: BAM-LIRA
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: TRIPLE
Status: COMPLETED
Enrollment: 52
Start: 2019-03-07
Primary completion: 2021-03-10
Lead sponsor: Filip Krag Knop
Conditions: Bile Acid Malabsorption
Interventions: DRUG:Liraglutide 6 MG/ML; DRUG:Colesevelam
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in stool fequency [7 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.